Investor web
contact image

Contact:

Ulrika Björk, CEO
Tel: +46 70 92 11 275
ulrika@polygiene.com 

Bulletin from the annual shareholders’ meeting in Polygiene AB (publ) on May 17, 2019

17 May 2019 Regulatory Information

Today, on May 17, 2019 an annual shareholders’ meeting was held in Polygiene AB (publ). A summary of the resolutions adopted follows below. All resolutions were adopted with the required majority of votes.

Resolution on adoption of accounts and distribution of the company’s profit

The annual shareholders’ meeting resolved to adopt the profit and loss statement and balance sheet. The annual shareholders’ meeting also resolved to distribute the company’s profit in accordance with the proposal from the board in the annual report meaning that no dividends are paid for the financial year 2018 and that available funds are brought forward.

Discharge from liability for the members of the board and the CEO

The annual shareholders’ meeting resolved to discharge the members of the board and the CEO from liability for the financial year 2018.

Election of board members and auditor as well as remuneration for the board members and auditor

The annual shareholders’ meeting resolved, in accordance with the proposal from the Nomination Committee, to re-elect Jonas Wollin, Martin Kössler and Daniel Röme as ordinary board members and to elect Ebba Fåhraeus and Håkan Lagerberg as new ordinary board members. Jonas Wollin was re-elected as Chairman of the board. Remuneration to the board shall be paid with SEK 225,000 to the Chairman of the board and with SEK 125,000 to each of the other board members. Lennart Holm, Jonas Sjögren and Daniel Oelker had declined re-election as board members.

Furthermore, the annual shareholders’ meeting resolved, in accordance with the proposal from the Nomination Committee, to re-elect Grant Thornton Sweden AB as auditor and that remuneration for the auditor shall be paid in accordance with customary norms and approved invoice. Grant Thornton Sweden AB has informed that Per Kjellander will continue to be appointed as the responsible auditor.

Resolution on instruction and charter for the Nomination Committee

The annual shareholders’ meeting resolved, in accordance with the proposal from the Nomination Committee, that a Nomination Committee shall be appointed before coming election and remuneration. The Nomination Committee shall comprise four members – one representative for each of the three largest shareholders on the last banking day in September, together with the Chairman of the board. Furthermore, an instruction and charter for the Nomination Committee was adopted.

Resolution on authorization regarding new share issues

The annual shareholders’ meeting resolved, in accordance with the proposal from the board of directors, to authorize the board of directors, up until the next annual shareholders’ meeting, at one or several occasions, with or without deviation from the shareholders’ preferential rights and with or without provisions regarding contribution in kind, set-off or other conditions, to issue shares. The reason for why a deviation from the shareholders’ preferential rights should be possible is to enable the company to source working capital, to be able to execute acquisitions of companies or operating assets as well as to enable new issues to industrial partners within the framework of partnerships and alliances. The total number of shares that may be issued shall not exceed 2,279,556 shares, which corresponds to a dilution of approximately 10 per cent calculated on the current number of shares. In case the authorization is used for a new issue with deviation from the shareholders’ preferential rights, the issue shall be made on market terms.

Resolution on implementation of a warrant program by way of (A) directed issue of warrants; and (B) approval of transfer of warrants

The annual shareholders’ meeting resolved, in accordance with the proposal from the board of directors, to implement a warrant program for employees and consultants in the company based on issue and transfer of warrants.

The warrant program shall comprise a maximum of 300,000 warrants. Each warrant shall entitle to subscription of one new share in the company. The subscription price per share shall correspond to 200 per cent of the volume weighted average price according to Nasdaq First North’s official price list for shares in the company during the period as from and including 20 May 2019 to and including 27 May 2019. Subscription of shares by virtue of the warrants may be effected as from 1 June 2022 up to and including 30 June 2022.

The warrants shall be issued to a wholly owned subsidiary to the company against cash consideration which shall correspond to the warrant’s fair market value calculated in accordance with the Black Scholes formula. The calculation of the fair market value of the warrants shall be established by Öhrlings PricewaterhouseCoopers AB in connection with the expiration of the measurement period on 27 May 2019. Transfer to participants under the warrant program shall be made against cash consideration which shall correspond to the fair market value of the warrant calculated in accordance with the Black Scholes formula.

The reasons for the implementation of the warrant program and the deviation from the shareholders’ preferential rights are to be able to create possibilities for the company to retain competent staff through the offering of a long term ownership engagement for the employees and consultants in the company. Such ownership engagement is expected to stimulate the employees and consultants in the company to an increased interest for the business and the earnings trend as well as to increase the feeling of connectedness with the company. Since the warrants in the warrant program will be transferred to the participants at the fair market value, the company’s assessment is that the company will not incur any social costs in relation to the warrant program. The costs related to the warrant program will hence only be composed of limited costs for implementation and administration of the program. In case all warrants issued within the warrant program are utilized for subscription of new shares, a total of 300,000 new shares will be issued, which corresponds to a dilution of approximately 1.4 per cent of the company’s share capital and votes after full dilution, calculated on the number of shares that will be added upon full utilization of all warrants issued under the warrant program.

Malmö on May 17, 2019

Polygiene AB (publ)

This information was submitted for publication, through the agency of the contact person set out below, at May 17, 2019, at 16:00 CET.  

For more information, visit www.ir.polygiene.com or contact:
The Company’s IR at e-mail: ir@polygiene.com
Ulrika Björk, CEO, Mobile: +46 (0) 70 921 12 75, e-mail: ubj@polygiene.com

Subscribe





Press releases